Koshinski Asset Management
CRMD icon

Koshinski Asset Management’s CorMedix CRMD Stock Holding History

Koshinski Asset Management’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-280
Closed -$1.53K – 844
2022
Q1 		$1.53K Hold
280
– – ﹤0.01% 2017
2021
Q4 		$1.27K Hold
280
– – ﹤0.01% 2054
2021
Q3 		$1.3K Buy
+280
New +$1.63K ﹤0.01% 2080

Other funds holding CRMD

Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $22.7B AUM 59.88% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $27.6B AUM 31.92% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Koshinski Asset Management's CRMD Position: Q2 2022 in Review

Koshinski Asset Management sold out of CorMedix (CRMD) in Q2 2022, closing a stake of 280 shares — an estimated $1.53K sold.

Koshinski Asset Management first reported a position in CRMD in Q3 2021 and held it in 3 quarters. The position peaked at $1.53K in Q1 2022. 74 funds tracked by Wall St. Rank hold CRMD as of Q2 2022.

  • Koshinski Asset Management reported no remaining CorMedix position as of Q2 2022 after selling out during the quarter.
  • Koshinski Asset Management sold 280 CorMedix shares in Q2 2022, an estimated $1.53K.
  • Koshinski Asset Management first reported a position in CorMedix in Q3 2021 and held it in 3 quarters.
  • Koshinski Asset Management's CorMedix position peaked at $1.53K in Q1 2022.
  • 74 funds tracked by Wall St. Rank held CorMedix as of Q2 2022.

Based on Koshinski Asset Management's 13F filing for Q2 2022, filed 12 Jul 2022.